Hjem › Akut myelogen leukemi › Delaware
Kliniske studier for Akut myelogen leukemi i Delaware
7 studier for Akut myelogen leukemi søker deltakere på steder i Delaware.
Offisiell studietekst (engelsk)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Medical Oncology Hematology Consultants, PA, Newark
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06852222A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Alfred I duPont Hospital for Children, Wilmington
RekruttererFase 3
6 Months – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04293562Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- Alfred I duPont Hospital for Children, Wilmington
RekruttererFase 3
Alder 1 til 25 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07022678The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Alfred I duPont Hospital for Children, Wilmington
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- Nemours Alfred I. Dupont Hospital for Children, Wilmington
RekruttererFase 3
29 Days – 21 Years · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05183035A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Nemours - Alfred I. duPont Hospital for Children, Brandywine
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Medical Oncology Hematology Consultants, Newark
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 31. okt. 2025 · NCT06549790Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.